Treatment Related Cancer Clinical Trial
Official title:
Therapeutic CARE of the Bronchial Cancer Not in Small Cell: Security of the Dispensation of Medicine by the Implementation of a Card of Coordination of Care Relative to the Medicinal Treatments Got Out of it From Hospitalization
The continuity of the medicinal care between the city and the hospital stays a major
organizational stake and of safety of patients' therapeutic care.This takeover is more
complex when it concerns pathology needed lots of hospitalization and included the
intervention of multiple healthcare practionners. This is clearly the case of cancer
coverage.
The optimization of the therapeutic suppor in town is based on pharmaceutical advice
strengthening but also on the pharmaceutical analysis to check the entire treatments'
prescription and eventual medicinal interactions which ensue from it.That's why it's
important to have a medicinal conciliation that takes into account all the medecine taken or
have to be taken by the patient.
A specific support was developped by nurses , doctors and pharmacist ; it's a care
coordination card that can be put easely in a pocket by the patient.
The aim of the study is that this card can be also used as a communication tools by sharing
the prescription done at the release of hospital by using an IT link (flea datamatrix) for
the patients Via the use of an IT link (flea datamatrix) for the patients whose pathology is
complex in term of extra hospital coverage.
The aim of this strudy is to evaluate with community pharmacists the impact of a new information system on the prevalence of dispensing difficulties reported by pharmacies when hospitalized patients leave the city. This information system will be based on the care coordination card implemented by a secure computer link allowing the use of information on treatments prescribed at the end of hospitalization. Patient management is not changed by this protocol. Only the information of the pharmacist, which is the object of the study, is increased. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05217069 -
FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
|
Phase 2 | |
Active, not recruiting |
NCT05185388 -
Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017
|
||
Withdrawn |
NCT04253249 -
Pancreatic Cyst Ablation With a Monopolar Radiofrequency Ablation Probe
|
||
Recruiting |
NCT03377829 -
A Multicenter Trial of PLA vs. Surgery for Treating PTMC
|
N/A | |
Not yet recruiting |
NCT04034173 -
Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
|
Phase 2 |